Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer

NCT00499031 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

NETWORK

Sponsor class

Conditions

Cervical Squamous Cell Carcinoma
Recurrent Cervical Carcinoma

Interventions

BIOLOGICAL: Cetuximab

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]